GM0N Stock Overview
A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Globus Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$79.50 |
| 52 Week High | US$90.50 |
| 52 Week Low | US$46.60 |
| Beta | 1.19 |
| 1 Month Change | -9.14% |
| 3 Month Change | 3.92% |
| 1 Year Change | 60.28% |
| 3 Year Change | 40.96% |
| 5 Year Change | 52.88% |
| Change since IPO | 592.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| GM0N | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -5.4% | 1.4% | 2.7% |
| 1Y | 60.3% | -2.8% | 17.0% |
Return vs Industry: GM0N exceeded the German Medical Equipment industry which returned -2.8% over the past year.
Return vs Market: GM0N exceeded the German Market which returned 17% over the past year.
Price Volatility
| GM0N volatility | |
|---|---|
| GM0N Average Weekly Movement | 3.9% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: GM0N has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: GM0N's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 5,000 | Dan Scavilla | www.globusmedical.com |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.
Globus Medical, Inc. Fundamentals Summary
| GM0N fundamental statistics | |
|---|---|
| Market cap | €10.89b |
| Earnings (TTM) | €87.21m |
| Revenue (TTM) | €2.36b |
124.9x
P/E Ratio4.6x
P/S RatioIs GM0N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GM0N income statement (TTM) | |
|---|---|
| Revenue | US$2.48b |
| Cost of Revenue | US$816.66m |
| Gross Profit | US$1.66b |
| Other Expenses | US$1.57b |
| Earnings | US$91.51m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 20, 2025
| Earnings per share (EPS) | 0.67 |
| Gross Margin | 67.05% |
| Net Profit Margin | 3.69% |
| Debt/Equity Ratio | 10.7% |
How did GM0N perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 17:40 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Globus Medical, Inc. is covered by 27 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Matt Miksic | Barclays |
| Craig Bijou | BofA Global Research |